N-苯磺酰基-3-乙酰基吲哚羰基酰腙类衍生物合成及其体外抗HIV-1活性研究（英文）

基于长期进行的抗HIV-1抑制剂研究,通过优化路线并设计合成了26个N-苯磺酰基-3-乙酰基吲哚羰基酰腙类衍生物(3a～3z)。该方法环保,为今后制备腙类化合物提供了绿色合成途径。所有目标化合物在体外均测定了其对HIV-1抑制活性。结果表明,化合物3a、3g、3t和3w～3y表现出较好的抗HIV-1活性,特别是N-苯磺酰基-3-乙酰基吲哚-3-甲基苯甲酰腙(3a)和N-(3-硝基)-苯磺酰基-3-乙酰基-6-甲基吲哚-2-噻吩甲酰腙(3t)表现出显著的抗HIV-1活性,其对应EC_(50)值分别为0.77和0.74μg/mL,TI值分别为259.74和270.27。因此,化合物3a和3t可作为候选化合物经进一步结构优化研究其HIV-1活性。     

吲哚-6-酰腙类化合物的微波合成及其抗菌活性研究

把酰腙类结构引入吲哚环中, 合成一类新型的吲哚-6-酰腙化合物, 以期为新药筛选提供先导化合物. 在微波辐射条件下, 以较高的产率得到14个未见报道的新化合物, 其结构均经1H NMR, IR, MS及元素分析确证, 并测试了化合物的抑菌活性.     

丹皮酚苯磺酰腙类衍生物的合成及杀粘虫活性研究

丹皮酚可作用于乙酰胆碱酯酶、穿过血脑屏障,该作用机理为使其可能开发成为新型杀虫剂。鉴于此,本文合成了5个丹皮酚苯磺酰腙类衍生物(5a～5e),并评价了它们对威胁农作物的害虫的杀虫活性。在1mg/mL浓度下,以川楝素为阳性对照,采用小叶碟添加法测定化合物3和5a～5e的杀粘虫活性。其中,化合物5e杀虫活性显著,最终校正死亡率(FMR=50.0%)与商品化植物源杀虫剂川楝素等同。初步构效关系研究表明,丹皮酚羰基位修饰是可行的;中间体3的亚胺位磺化修饰可提高杀虫活性,且磺化取代基不同活性差异显著。此外,实验还发现试虫取食了附有供试化合物的叶片后在幼虫期、化蛹期和羽化期均出现不同程度、不同状况的非正常生长。     

甲氧羰基吲哚-3-甲醛苯腙的合成

甲氧羰基吲哚-3-甲醛与苯肼在酸性条件下通过缩合反应合成了4个未见文献报道的新化合物甲氧羰基吲哚-3-甲醛苯腙,其结构经1HNMR,IR和MS确证。     

新型PTP 1B抑制剂喹啉腙及酰腙化合物的合成与活性研究

喹啉腙及喹啉酰腙类化合物具有广泛的生物活性.本文设计合成了29个未见报道的4-(2-芳基)喹啉芳腙和芳酰腙类化合物,采用光吸收检测法测试所合成化合物对蛋白酪氨酸磷酸酶PTP 1B的抑制作用.结果 表明,喹啉腙类化合物对PTP 1B具有显著的酶抑制作用,在20μ g/mL浓度时,有21个化合物对PTP 1B抑制率在80％...     

新型薁类-1-酰腙化合物的合成及抗菌活性研究

为了合成和研究具有薁类结构物质的新的生物活性, 以1-薁类羧酸甲酯为起始原料, 经过酰肼化、与芳香醛及酮类化合物的缩合, 合成了含有酰腙类结构的薁类衍生物, 其结构经1H NMR, IR和元素分析确证. 对所得化合物进行了抗菌活性测试, 初步表明它们具有一定的活性.     

含酰腙吲哚片段的蓝刺头碱衍生物的设计、合成及抗烟草花叶病毒活性

为了发现高活性的抗病毒化合物,以蓝刺头碱为先导,运用骨架跃迁策略,设计合成了15个含有酰腙吲哚片段的蓝刺头碱衍生物,并通过1H NMR、13C NMR和HRMS确证了其结构,研究了其对烟草花叶病毒（TMV）的钝化、治疗和保护活性。研究结果表明,部分化合物具有较高的抗TMV活性。其中,化合物4n（43.5%,40.1%,38.7%）抗TMV的钝化、治疗和保护活性高于病毒唑（38.6%,36.5%,37.2%）和先导化合物L2（40.5%,34.7%,38.3%）。化合物4d（40.8%）、4f（42.0%）对TMV的钝化活性优于病毒唑（38.6%）和先导化合物L2（40.5%）。化合物4I（38.4%）对TMV的钝化活性与病毒唑（38.6%）相当。化合物4f（36.4%）对TMV的保护活性与病毒唑（37.2%）相当。化合物4n有望成为一种潜在的抗病毒农药。     

新型苯甲醛-β-咔啉-3-酰腙的合成及其除草活性

以L-色氨酸为起始原料,经Pictet-Spengle环合、酯化、氧化、氨解等反应合成了3个新型的四氢β-咔啉-3-酰腙(5a~5c)和3个新型的β-咔啉-3-酰腙衍生物(8a~8c),其结构经1H NMR表征。初步除草活性测试结果表明:在用药量为200 mg·L-1时,5a~5c和8a~8c的对白菜的抑制率均为100%;随着用药量降低,活性也随之减小;5a~5c的生长抑制率普遍比8a~8c好。     

基于咔唑的单-/双-硫代碳酰腙衍生物的合成及Cdc25B/PTP1B抑制活性评价

合成了一系列新型的基于咔唑的单-/双-硫代碳酰腙衍生物.利用IR、1H NMR、13C NMR和元素分析对其进行了结构表征.评价了目标化合物对Cdc25B和PTP1B的抑制活性,讨论了其结构与活性的关系.实验结果显示,大部分目标化合物对Cdc25B和PTP1B表现出良好的抑制活性.其中,1,5-双[(9-戊基-3-咔唑基)亚甲基]硫代碳酰腙(4d)对Cdc25B的抑制活性最高,IC50为(0.23±0.02)μg/m L.1,5-双[(9-乙基-3-咔唑基)亚甲基]硫代碳酰腙(4a)对PTP1B的抑制活性最高, IC50为(1.00±0.16)μg/m L.对目标化合物4a和4d进行分子对接研究和密度泛函理论(DFT)计算,结果表明,目标化合物4d和4a分别进入到了Cdc25B和PTP1B酶的活性位点区域,有活性作用的主要是硫代碳酰腙和咔唑基团.     

3位苯甲酰腙和亚氨基取代硫脲取代的吲哚满二酮衍生物的合成及对AHAS的抑制活性

基于前期生物设计AHAS抑制剂的研究,设计合成了15个吲哚满二酮类衍生物,其中9个为新化合物,其结构均经过1H NMR,MS和元素分析确证,并对所有化合物进行了离体和活体活性测试.实验结果表明,这类化合物在体内和体外均具有一定的生物活性,在离体活性测试中,所有化合物在100μg/mL浓度下对拟南芥AHAS均表现出明确的抑制活性,其中化合物4d,4e,5a和5f在10μg/mL浓度下仍然对AHAS表现出45%以上的抑制率,但此类化合物除草活性普遍较差.     

7-二乙氨基香豆素腙及酰腙衍生物的制备及乙酰胆碱酯酶抑制活性研究

本论文采用亚活性结构拼接的方法,以7-N,N-二乙氨基-4-甲基香豆素为原料,经二氧化硒氧化,然后与取代肼和取代酰肼反应,合成了13个7-N,N-二乙氨基香豆素腙及酰腙衍生物。所有目标化合物经1H NMR和MS进行结构确证。体外抑制乙酰胆碱酯酶活性结果表明,目标化合物4a和4c对乙酰胆碱酯酶具有较强的抑制活性,其IC50值分别为42. 89和90. 32μmol/L。初步构效关系研究表明,酰腙衍生物对乙酰胆碱酯酶的抑制活性比腙类衍生物好。     

氟喹诺酮-3-N-酰胺类衍生物的合成与抗肿瘤活性

为扩展氟喹诺酮由抗菌活性向抗肿瘤活性转化的结构修饰策略,利用药效团生物电子等排及其拼合和骨架迁越药物化学分子构建方法,以酰胺基作为氟喹诺酮C-3位羧基的生物电子等排体,氟喹诺酮骨架为酰胺基的功能修饰基,设计合成了氟喹诺酮-3-N-酰胺类目标化合物。其结构经元素分析和光谱数据确证。体外抗肿瘤实验结果表明,目标化合物对Hep-3B细胞和Capan-1细胞的抗增殖活性均显著强于母体环丙沙星的活性,尤其对Hep-3B细胞的抑制活性最强。因此,用酰胺基来替代C-3羧基有利于提高氟喹诺酮的抗肿瘤活性。     

含4(3H)-喹唑啉酮结构的取代1,3,4-噁二唑(噻二唑)化合物的合成及抗菌活性研究

以2-胺基苯甲酸为原料,通过环化、缩合、肼解、环化、硫醚化和氧化等步骤,合成了10个含喹唑啉酮取代1,3,4-噁二唑(噻二唑)化合物。通过1H NMR、13C NMR、MS 和元素分析进行确证其结构。初步抑菌活性测试表明,化合物浓度在50 μg/mL时,对葡萄座腔菌(Botryosphaeria dothidea)、拟茎点霉菌(Phomopsis sp.)和灰霉菌(B. cinerea)具有中等抑制活性。另外,目标化合物对猕猴桃溃疡病(Pseudomonas syringae pv. actinidia)均具有一定的抑制活性,其中化合物6a和6b对猕猴桃溃疡病的EC50值为11.7 μg/mL和20.5 μg/mL,优于对照药剂叶枯唑(24.5 μg/mL)。这类化合物具有较好抗菌的生物活性,在此基础上进行结构优化,有望发现较高活性化合物。     

Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

When developing drugs against SARS-CoV-2, it is important to consider the characteristics of patients with different co-morbidities. People infected with HIV-1 are a particularly vulnerable group, as they may be at a higher risk than the general population of contracting COVID-19 with clinical complications. For such patients, drugs with a broad spectrum of antiviral activity are of paramount importance. Glycyrrhizinic acid (Glyc) and its derivatives are promising biologically active compounds for the development of such broad-spectrum antiviral agents. In this work, derivatives of Glyc obtained by acylation with nicotinic acid were investigated. The resulting preparation, Glycyvir, is a multi-component mixture containing mainly mono-, di-, tri- and tetranicotinates. The composition of Glycyvir was characterized by HPLC-MS/MS and its toxicity assessed in cell culture. Antiviral activity against three strains of SARS-CoV-2 was tested in vitro on Vero E6 cells by MTT assay. Glycyvir was shown to inhibit SARS-CoV-2 replication in vitro (IC₅₀2–8 μM) with an antiviral activity comparable to the control drug Remdesivir. In addition, Glycyvir exhibited marked inhibitory activity against HIV pseudoviruses of subtypes B, A6 and the recombinant form CRF63_02A (IC₅₀ range 3.9–27.5 µM). The time-dependence of Glycyvir inhibitory activity on HIV pseudovirus infection of TZM-bl cells suggested that the compound interfered with virus entry into the target cell. Glycyvir is a promising candidate as an agent with low toxicity and a broad spectrum of antiviral action.     

Cathodic deposition of ternary In+As+Sb alloys and formation of InAsxSb1−x

In+As+Sb alloys have been deposited onto Ni and Ti cathodes from tartaric acid solutions at pH 2. Homogeneous deposits of composition suitable for achieving InAs_xSb_1−x can be obtained from this medium. The As-to-Sb ratio can be controlled by properly selecting solution composition and deposition potential.X-ray photoelectron spectroscopy and X-ray diffraction analyses show that formation of III–V compounds occurs at room temperature. In reacts preferentially with As rather than with Sb, but crystalline phases formed at room temperature are Sb-rich. After annealing the In+As+Sb alloys at 250°C, the composition calculated from cell parameters appears similar to that measured by energy-dispersive X-ray analysis, suggesting that the entire deposit has been converted into the InAs_xSb_1−x crystalline phase.     

Synthesis and in vitro-Anti-hepatitis B Virus Activities of Several Ethyl 5-Hydroxy-lH-indole-3-carboxylates

A series of ethyl 5-hydroxyindole-3-earboxylates 6a-10r was designed and synthesized. The structures of all the compounds were confirmed by IR, ^1H NMR, and MS and their anti-hepatitis B virus （HBV） activities were evaluated in 2.2.15 cells. Among them, compound 7g { ethyl 5-hydroxy-2- [ （ 3-methoxyphenylsulfinyl ） methyl ] -1-methyl-4- [ （4-methylpiperazin-1-yl） methyl ]-1H-indole-3-carboxylate} displays a significant anti-HBV activity, which is more potent than the positive control lamivudine.     

In situ X-ray diffraction study of reduction processes of Fe3O4- and Fe1−xO-based ammonia-synthesis catalysts

The temperature-programmed reduction process of two types of industrial ammonia-synthesis catalysts, A110 and ZA-5, which are, respectively, based on Fe₃O₄ and Fe_1−xO precursors, were studied by in situ X-ray power diffraction (XRD). It has been found that the ZA-5 has lower reduction temperature and faster reduction rate, and its active phase α-Fe possesses a higher value of lattice microstrain than A110. The simulation based on Rietveld refinement has also shown that the shape of α-Fe grain of ZA-5 has a mixed shape of cube and sphere with more exposing (111) and (211) planes, while that of A110 looks like a concave cube with more exposing (110) planes. Based on the results obtained, a growth model of α-Fe during the reduction of Fe₃O₄- and Fe_1−xO-based ammonia-synthesis catalysts is proposed, and the origins for the activity difference has been also discussed.     

Nucleophilic Fluoroalkylation of α,β‐Unsaturated Carbonyl Compounds with α‐Fluorinated Sulfones: Investigation of the Reversibility of 1,2‐Additions and the Formation of 1,4‐Adducts

A detailed investigation of the reactions of PhSO₂CF₂H and PhSO₂CH₂F with (E)‐chalcone (=(E)‐1,3‐diphenylprop‐2‐en‐1‐one) at low temperatures revealed that these two reactions were kinetically controlled, and the ratios of 1,2‐ vs. 1,4‐adducts, which did not change much over time at these temperatures, reflect the relative rates of the two reaction pathways. The controlled experiments of converting the PhSO₂CF₂‐ and PhSO₂CHF‐substituted 1,2‐adducts to 1,4‐adducts showed that these isomerizations are not favored due to the low stability and hard‐soft nature of PhSO₂CF and PhSO₂CHF^? anions. Moreover, taking advantage of the remarkable stability and softness of (PhSO₂)₂CF^? anion, an efficient thermodynamically controlled isomerization of (PhSO₂)₂CF‐substituted 1,2‐adduct to 1,4‐adduct was achieved for the first time.